Camagüey, January 11 (RHC)-- In 2017, more than 460 Cuban patients benefited from HeberFERON –a skin cancer medication, developed by the Havana-based Genetic Engineering and Biotechnology Center.
The figure was released during a scientific event in Camagüey to assess the drug's efficiency. Cuban researchers and academics are discussing the results over the past twelve months in such provinces as Cienfuegos, Sancti Spíritus, Ciego de Ávila y Villa Clara, with a view to extending its use to other Cuban regions.
During the event, experts revealed that more than 50% of patients responded favorably to the three-week treatment with the medication.
A therapeutic alternative, resulting from the combination of two interferons, HeberFERON delays tumor growth and reduces or totally eliminates basal cell carcinoma regardless of type, size or place.
Yutdelis Roben, National Coordinator of the HeberFERON Program, told the press that the medication is being used to treat patients in 47 health centers across the country, including 17 primary health centers.
Cuban Patients Benefit from Domestic Skin Cancer Medication
![](https://www.radiohc.cu/articles/7258-heberferon-cuba.jpg)
Articles en relation
Commentaires
Laissez un commentaire
Tous les champs sont requisPlus de visites
- Díaz-Canel à l'Assemblée nationale : il est temps d'aller au-delà des diagnostics et de passer à l'action
- La population effective de Cuba diminue
- Nouvelles demandes adressées aux États-Unis pour qu'ils retirent Cuba de la liste des pays terroristes
- Message du Premier secrétaire du Comité central du Parti communiste de Cuba et Président de la République, lors de la séance d'ouverture de la deuxième réunion de haut niveau du Forum sur l'action mondiale pour le développement partagé
- Quelle est l'ampleur du terrorisme dénoncé par Cuba aux Etats-Unis ?